Gland Pharma Ltd shares jump 1.91% as company appoints new CEO
Why did Gland Pharma Ltd shares jump today?
Gland Pharma Ltd shares saw a notable increase of 1.91% in early trading on Friday. As of 09:16 AM, the stock was trading at ₹2950.0 per share on the BSE.
This positive movement is attributed to the company's announcement of a key leadership appointment. As per the notification submitted to the stock exchange, the Board of Directors, based on the recommendation of the Nomination and Remuneration Committee, has approved the appointment of Mr. Deepak Sapra as the new Chief Executive Officer (CEO) of the company.
The market's reaction suggests that investors view this appointment as a strategic and positive step for the pharmaceutical company. The leadership change, subject to Mr. Sapra's acceptance of the offer, is being seen as a move to potentially steer the company towards growth and stability, which has boosted investor confidence in its future prospects.
What does Gland Pharma Ltd do?
Gland Pharma Limited is a company listed on major Indian stock exchanges, specifically the BSE Limited and the National Stock Exchange of India Limited. It is registered as a publicly traded entity, as indicated by its listing with the Scrip Code 543245 and Symbol GLAND. The company's official correspondence is handled through its Corporate Relationship Department located in Mumbai.
The provided information focuses on a regulatory notification regarding the appointment of a Chief Executive Officer, which is being communicated to stock exchanges in compliance with SEBI regulations for listed companies. The company's administrative presence is established at its address in the Bandra Kurla Complex, Mumbai.
Gland Pharma Ltd Financials
In CroresGland Pharma Ltd's financials indicate growth in both revenue and profit between December 2025 and March 2026. Revenue rose from ₹1,695.36 crores to ₹1,742.79 crores, reflecting a quarterly increase of ₹47.43 crores. Net profit showed stronger growth, jumping from ₹261.48 crores to ₹366.68 crores, an increase of ₹105.2 crores over the same period. This indicates a trend of expansion, with profitability growing at a notably faster pace than top-line revenue.
Gland Pharma Ltd Shareholding Pattern
Promoter holding stands at 51.77% of the total share capital. Foreign Institutional Investors (FIIs) hold 8.74% stake in the company, while Domestic Institutional Investors (DIIs) hold 30.44%. Public shareholders hold the remaining 9.06% stake in Gland Pharma Ltd.
Gland Pharma Ltd FAQs
Q: Why did Gland shares jump 1.91% today?
Appointment of Chief Executive Officer of the Company. This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Gland Pharma Ltd?
As per the latest data, promoters hold 51.77% stake in Gland Pharma Ltd, while FII holding stands at 8.74%. Domestic institutional investors hold 30.44%, and public shareholders account for 9.06% of the equity.
Q: What is the current stock price of Gland Pharma Ltd?
Gland Pharma Ltd shares are currently trading at ₹2950.0, recording a gain of 1.91% from the previous close.
Q: What is the market capitalization of Gland Pharma Ltd?
The company currently has a market capitalization of ₹48665.16 crore, reflecting its valuation in the Indian equity market.